Innospec (IOSP) Liabilities and Shareholders Equity (2010 - 2026)

Innospec (IOSP) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 2.55% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $7.3 billion (up 3.57% YoY), and the FY2025 full-year result was $1.8 billion, up 5.63% from the prior year.
• Liabilities and Shareholders Equity retreated to $1.8 billion in Q1 2026, from $1.8 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2025 to a low of $1.6 billion in Q4 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity climbed 13.86% in 2022 and fell 3.03% in 2023, its largest moves.
• Tracing IOSP's Liabilities and Shareholders Equity over 5 years: stood at $1.6 billion in 2022, then gained by 6.47% to $1.7 billion in 2023, then increased by 1.6% to $1.7 billion in 2024, then increased by 5.63% to $1.8 billion in 2025, then slipped by 0.69% to $1.8 billion in 2026.
• Business Quant data shows IOSP's Liabilities and Shareholders Equity at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.